Israel Englander Glaukos Corp Transaction History

Millennium Management LLC

$175 Billion
Q1 2025

A detailed history of Israel Englander (Millennium Management LLC) transactions in Glaukos Corp stock. As of the latest transaction made, Millennium Management LLC holds 78,232 shares of GKOS stock, worth $7.39 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

78,232

Previous 2,000 3811.6%

Holding current value

$7.39 Million

Previous $299,000 2474.92%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$96.6 - $161.22 $30.4 Million - $50.8 Million	-314,991 Reduced 80.1%	78,232 $7.7 Million
Q4 2024 Feb 14, 2025	BUY	$126.42 - $152.67 $19.1 Million - $23.1 Million	150,997 Added 62.34%	393,223 $59 Million
Q3 2024 Nov 14, 2024	SELL	$113.62 - $135.39 $118 Million - $140 Million	-1,035,705 Reduced 81.05%	242,226 $31.6 Million
Q2 2024 Aug 14, 2024	SELL	$89.48 - $118.35 $4.42 Million - $5.84 Million	-49,366 Reduced 3.72%	1,277,931 $151 Million
Q1 2024 May 15, 2024	BUY	$76.4 - $96.33 $23.2 Million - $29.3 Million	303,964 Added 29.7%	1,327,297 $125 Million
Q4 2023 Feb 14, 2024	SELL	$59.53 - $85.11 $25.7 Million - $36.7 Million	-431,072 Reduced 29.64%	1,023,333 $81.3 Million
Q2 2023 Aug 14, 2023	BUY	$45.44 - $71.21 $7.1 Million - $11.1 Million	156,353 Added 12.05%	1,454,405 $104 Million
Q1 2023 May 15, 2023	BUY	$43.88 - $52.48 $39.5 Million - $47.2 Million	899,776 Added 225.92%	1,298,052 $65 Million
Q4 2022 Feb 14, 2023	BUY	$40.82 - $57.75 $1.14 Million - $1.62 Million	27,981 Added 7.56%	398,276 $17.4 Million
Q3 2022 Nov 14, 2022	BUY	$46.84 - $58.49 $11.8 Million - $14.7 Million	251,352 Added 211.32%	370,295 $19.7 Million
Q2 2022 Aug 15, 2022	SELL	$34.86 - $63.77 $22.3 Million - $40.7 Million	-638,890 Reduced 84.3%	118,943 $5.4 Million
Q1 2022 May 16, 2022	BUY	$44.33 - $57.82 $33.4 Million - $43.5 Million	753,043 Added 15721.15%	757,833 $43.8 Million
Q4 2021 Feb 14, 2022	SELL	$40.27 - $56.99 $5.45 Million - $7.72 Million	-135,409 Reduced 96.58%	4,790 $213,000
Q3 2021 Nov 15, 2021	BUY	$47.43 - $84.23 $6.02 Million - $10.7 Million	126,930 Added 956.59%	140,199 $6.75 Million
Q2 2021 Aug 16, 2021	BUY	$73.06 - $97.7 $619,767 - $828,789	8,483 Added 177.25%	13,269 $1.13 Million
Q1 2021 May 17, 2021	SELL	$70.43 - $97.42 $3.66 Million - $5.06 Million	-51,924 Reduced 91.56%	4,786 $402,000
Q4 2020 Feb 16, 2021	SELL	$48.9 - $75.26 $8.97 Million - $13.8 Million	-183,413 Reduced 76.38%	56,710 $4.27 Million
Q2 2020 Aug 14, 2020	BUY	$28.78 - $46.83 $5.5 Million - $8.96 Million	191,243 Added 391.25%	240,123 $9.23 Million
Q1 2020 May 14, 2020	SELL	$25.53 - $70.14 $10.6 Million - $29.2 Million	-416,172 Reduced 89.49%	48,880 $1.51 Million
Q4 2019 Feb 14, 2020	BUY	$54.18 - $65.64 $23.8 Million - $28.8 Million	438,443 Added 1647.72%	465,052 $25.3 Million
Q3 2019 Nov 14, 2019	SELL	$58.58 - $83.91 $2.17 Million - $3.11 Million	-37,113 Reduced 58.24%	26,609 $1.66 Million
Q2 2019 Aug 14, 2019	BUY	$63.59 - $78.71 $1.76 Million - $2.18 Million	27,645 Added 76.63%	63,722 $4.81 Million
Q1 2019 May 14, 2019	SELL	$50.75 - $80.54 $151,641 - $240,653	-2,988 Reduced 7.65%	36,077 $2.83 Million
Q4 2018 Feb 14, 2019	SELL	$52.18 - $67.93 $23.7 Million - $30.8 Million	-454,068 Reduced 92.08%	39,065 $2.19 Million
Q3 2018 Nov 14, 2018	BUY	$38.13 - $68.37 $18.8 Million - $33.7 Million	493,133 New	493,133 $32 Million
Q2 2018 Aug 14, 2018	SELL	$27.62 - $44.51 $196,792 - $317,133	-7,125 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$26.05 - $34.5 $3.98 Million - $5.28 Million	-152,939 Reduced 95.55%	7,125 $220,000
Q4 2017 Feb 14, 2018	BUY	$24.5 - $36.01 $3.92 Million - $5.76 Million	160,064	160,064 $4.11 Million

Others Institutions Holding GKOS

# of Institutions

358

Shares Held

50.2M

Call Options Held

260K

Put Options Held

776K

View Full List

About GLAUKOS Corp

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $4.5B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

More about GKOS

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account